Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Oncotarget
|
January 11, 2020
Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy
Caroline K Søgaard, Anala Nepal, Voin Petrovic, et al.
FEBS Open Bio
|
July 11, 2018
The role of PCNA as a scaffold protein in cellular signaling is functionally conserved between yeast and humans
Camilla Olaisen, Hans Fredrik N Kvitvang, Sungmin Lee, et al.
Oncogene
|
December 23, 2022
PCNA regulates primary metabolism by scaffolding metabolic enzymes
Lisa M Røst, Synnøve B Ræder, Camilla Olaisen, et al.
Translational Oncology
|
December 16, 2014
Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide
Odrun A Gederaas, Caroline D Søgaard, Trond Viset, et al.
DNA Repair
|
January 28, 2012
The region of XRCC1 which harbours the three most common nonsynonymous polymorphic variants, is essential for the scaffolding function of XRCC1
Audun Hanssen-Bauer, Karin Solvang-Garten, Karin Margaretha Gilljam, et al.
Plos One
|
November 13, 2012
Human ALKBH4 interacts with proteins associated with transcription
Linn G Bjørnstad, Trine J Meza, Marit Otterlei, et al.
Data in Brief
|
April 4, 2017
Changes in cellular signaling proteins in extracts from A549, H460, and U2OS cells treated with cisplatin or docetaxel
Voin Petrovic, Camilla Olaisen, Animesh Sharma, et al.
Analytical Biochemistry
|
February 8, 2017
On-column trypsinization allows for re-use of matrix in modified multiplexed inhibitor beads assay
Voin Petrovic, Camilla Olaisen, Animesh Sharma, et al.
International Journal of Molecular Sciences
|
January 2, 2019
APIM-Mediated REV3L⁻PCNA Interaction Important for Error Free TLS Over UV-Induced DNA Lesions in Human Cells
Synnøve Brandt Ræder, Anala Nepal, Karine Øian Bjørås, et al.
The Journal of Experimental Medicine
|
June 22, 2005
B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
Bodil Kavli, Sonja Andersen, Marit Otterlei, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Oncotarget
|
January 11, 2020
Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy
Caroline K Søgaard, Anala Nepal, Voin Petrovic, et al.
FEBS Open Bio
|
July 11, 2018
The role of PCNA as a scaffold protein in cellular signaling is functionally conserved between yeast and humans
Camilla Olaisen, Hans Fredrik N Kvitvang, Sungmin Lee, et al.
Oncogene
|
December 23, 2022
PCNA regulates primary metabolism by scaffolding metabolic enzymes
Lisa M Røst, Synnøve B Ræder, Camilla Olaisen, et al.
Translational Oncology
|
December 16, 2014
Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide
Odrun A Gederaas, Caroline D Søgaard, Trond Viset, et al.
DNA Repair
|
January 28, 2012
The region of XRCC1 which harbours the three most common nonsynonymous polymorphic variants, is essential for the scaffolding function of XRCC1
Audun Hanssen-Bauer, Karin Solvang-Garten, Karin Margaretha Gilljam, et al.
Plos One
|
November 13, 2012
Human ALKBH4 interacts with proteins associated with transcription
Linn G Bjørnstad, Trine J Meza, Marit Otterlei, et al.
Data in Brief
|
April 4, 2017
Changes in cellular signaling proteins in extracts from A549, H460, and U2OS cells treated with cisplatin or docetaxel
Voin Petrovic, Camilla Olaisen, Animesh Sharma, et al.
Analytical Biochemistry
|
February 8, 2017
On-column trypsinization allows for re-use of matrix in modified multiplexed inhibitor beads assay
Voin Petrovic, Camilla Olaisen, Animesh Sharma, et al.
International Journal of Molecular Sciences
|
January 2, 2019
APIM-Mediated REV3L⁻PCNA Interaction Important for Error Free TLS Over UV-Induced DNA Lesions in Human Cells
Synnøve Brandt Ræder, Anala Nepal, Karine Øian Bjørås, et al.
The Journal of Experimental Medicine
|
June 22, 2005
B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
Bodil Kavli, Sonja Andersen, Marit Otterlei, et al.
Page
of 8